Glenmark Pharmaceuticals Ltd News

Glenmark to conduct clinical trials of its molecule on cancer patients_52506

Glenmark Pharmaceuticals on Monday said its unit has received approval from the DCGI to conduct phase 1 clinical trials of its novel molecule on patients with advanced solid tumors.

Nifty Pharma may have bottomed out; Aurobindo, Glenmark can rally up to 10%_45314

The Nifty Pharma index has crossed its near-term resistance at 13,700, and may spurt another 1.5 per cent.

Glenmark gets nod from US Food & Drug Administration for generic drug_24362

Glenmark Pharmaceuticals on Friday said its US-based unit has received approval from the US health regulator to market Metronidazole Vaginal gel, in the American market. The drug firm has received final approval by the United States Food & Drug Administration (USFDA) for its product which is a generic version of Bausch Health US LLC's MetroGel-Vaginal, the drug firm said in a statement. According to IQVIA sales data for the 12-month period ending November 2021, the MetroGel-Vaginal Gel achieved annual sales of approximately around USD 60.4 million. Glenmark's current portfolio consists of 173 products authorised for distribution in the US marketplace and 46 ANDA's pending approval with the USFDA. In addition to these internal filings, the drug firm continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio, Glenmark noted.

Nandish Shah recommends a Bull spread on Glenmark Pharma for January series_13469

Pharma as a sector looking good on the short term chart, according to Nandish Shah of HDFC Securities.

Glenmark, Alembic, Cipla: Pharma stocks on a booster dose this December_1947

Select pharma stocks look good on the technical charts and may jump up to 15 per cent in December. On the fundamental side, fears of Omicron variant spreading may also keep them in news and buzzing